Interleukin Genetics Inc is an AMEX listed security that has been trading in a range between $1.50 and $6.95 over the past year. With 27,601,640 shares outstanding, a recent price of $1.55 gives a total market capitalization of $42,506,525. While there are certainly larger companies, Interleukin Genetics Inc has definitely earned its place in the pack. Last year, Interleukin Genetics Inc created $-0.24 in earnings for every share outstanding.
Interleukin Genetics Inc is currently priced by the market at 0.00 times last year’s earnings. Many trading multiples around the world are quite attractive these days, but don’t be fooled. A Price to Earnings ratio of 0 simply means that the security didn’t make any money last year.
With a share price under $50 a share and earnings per share below $1 a share, Interleukin Genetics Inc is unlikely to be an interesting value proposition.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment